This molecule, tested on a J20 a mouse model overexpressing human APP with a mutation linked to familiar AD, and on Sprague–Dawley rats, improved memory capacity, blocked Aβ deposition, improved neuroinflammation, and re-established synaptophysin levels in the mouse hippocampus [128,129]. The gene discussed is APP; the disease is Alzheimer disease.